Search Results 331-340 of 14778 for albumin

1. A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma - Mayo Clinic

   Albumin ≥ 2 g/dL within 7 days prior to enrollment. Left ventricular ejection fraction (LVEF) ≥ 53% (or institutional normal; if the LVEF result is given ...

2. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

   Serum albumin ≥ 2.8 g/dL. Lipase < 2.0 x ULN and no radiologic or clinical evidence of pancreatitis. Urine protein/creatinine ratio (UPCR) ≤ 1 mg/mg ...

3. 177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer - Mayo Clinic

   Albumin ≥ 2.5 g/dL 13. Candidates for change in ARDT as assessed by the treating physician. Exclusion Criteria: Participants meeting any of the following ...

4. A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibito - Mayo Clinic

   Total Calcium (corrected for serum albumin). Participant must be able to swallow capecitabine tablets. Participant must be able to communicate with the ...

5. An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Soc, Versus SoC Alone, in Adult Male Patients With mHSPC - Mayo Clinic

   Albumin ≥2.5 g/dL 10. Human immunodeficiency virus (HIV)-infected patients who are healthy and have a low risk of acquired immune deficiency syndrome (AIDS)- ...

6. Study to Evaluate CCS1477 in Haematological Malignancies - Mayo Clinic

   Serum albumin > 2.5 g/dL. Exclusion Criteria: Any investigational agent, chemotherapy, immunotherapy or anticancer agents from a previous clinical study ...

7. Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

   Serum albumin ≥ 2 g/dL; Blood glucose normal; Not pregnant or nursing; Negative pregnancy test; Fertile patients must use effective contraception during and ...

8. Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye - Mayo Clinic

   Serum albumin ≥ 2.8 g/dL; Urine protein/creatinine ratio (UPCR) ≤ 1; if urine/protein creatinine (UPC) ≥ 1, then a 24-hour urine protein must be assessed ...

9. Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma - Mayo Clinic

   ... albumin > 3.0 g/Dl 8. Willingness and ability to consent (and assent if under age 18) for self to participate in study. Willingness and ability to comply ...

10. A Study Of Sonodynamic Therapy With SONALA-001 And Exablate 4000 Type 2.0 In Subjects With Progressive Or Recurrent Glioblastoma Multiforme (RGBM) - Mayo Clinic

    Albumin ≥3 g/dL. Potassium ≥LLN. Serum total calcium ≥LLN. Creatinine ≤1.5 x ULN OR Calculated creatinine clearance ≥60 mL/min using the Cockcroft-Gault ...